双极性疾病患者的血清ZO-1和奥克卢丁水平
Pınar Aydogan Avşar1, Merve Akkuş2
1Department of Child and Adolescent Psychiatry, Alanya Alaaddın Keykubat Unıversıty Training And Research Hospıtal, Alanya, Antalya, Turkey.
European archives of psychiatry and clinical neuroscience
|September 1, 2025
概括
在双相情感障碍患者中,血清中血脑屏障蛋白质ocludin和zonula occludens-1蛋白 (ZO-1) 的水平升高. 这表明血脑屏障的破坏可能导致双极性障碍
科学领域:
- 神经科学
- 精神病学
- 生物化学
背景情况:
- 双极性障碍 (BD) 有复杂的病因.
- 血脑屏障 (BBB) 通过紧密结节 (TJs) 保护中枢神经系统 (CNS).
- 对于健康的BBB功能来说,TJ蛋白质的完整性至关重要.
研究的目的:
- 在双相情感障碍患者中检测TJ蛋白质奥克卢丁和Zonula occludens-1蛋白质 (ZO-1) 的血清水平.
- 探索BBB完整性在双相情感障碍病因发生中的作用.
- 在BD中确定BBB泄漏的潜在生物标志物.
主要方法:
- 在40名BD患者 (躁狂和精神病发作) 和40名健康对照人群中比较血清奥克卢丁和ZO- 1水平.
- 使用协变性分析 (ANCOVA) 来评估群体差异.
- 根据年龄,性别,BMI和吸烟情况进行控制.
主要成果:
- 与对照组相比,双极性障碍患者的血清奥克卢丁和ZO-1水平显著较高.
- ANCOVA证实了该组对血清奥克卢丁和ZO-1水平的显著主要影响.
- 这些发现与年龄,性别,BMI和吸烟无关.
结论:
- 血清奥克卢丁和ZO-1的升高表明双极性疾病中血脑屏障受损.
- BBB功能障碍和神经炎症可能与BD病原发生有关.
- 奥克卢丁和ZO-1显示为BBB泄漏的潜在生物标志物,可能为未来的治疗提供信息.
相关概念视频
Bipolar Disorder
142
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
142
Mania and Antimanic Drugs: Overview
318
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
318
Negative and Cognitive Symptoms of Schizophrenia
120
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
120
Depressive Disorders: Etiology
165
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
165
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
945
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
945
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209


